New pharmaceutical formulation comprising cannabidiol and...

Details New pharmaceutical formulation comprising cannabidiol and... New pharmaceutical formulation comprising cannabidiol and...

A - Human Necessities

61

K

A61K 31/05 (2006.01) A61K 31/352 (2006.01) A61K 36/185 (2006.01) A61P 3/04 (2006.01) A61P 19/08 (2006.01) A61P 25/00 (2006.01)

Patent

CA 2692539

The present invention relates to a novel pharmaceutical formulation comprising a ratioed mix of: (i) one or more compounds that acts as an inverse agonist of the CB1 and/or CB2 receptor; and (ii) one or more compounds that acts as a neutral antagonist of the CB1 and/or CB2 receptor. Preferably both the inverse agonist of the CB1 and/or CB2 receptor and the neutral antagonist of the CB1 and/or CB2 receptor are cannabinoids. Preferably the cannabinoids are tetrahydrocannabidivarin (THCV) and cannabidiol (CBD).

La présente invention porte sur une nouvelle préparation pharmaceutique comprenant un mélange proportionné de : (i) un ou plusieurs composés qui agissent en tant qu'agoniste inverse du récepteur CB1 et/ou CB2; et (ii) un ou plusieurs composés qui agissent en tant qu'antagoniste neutre du récepteur CB1 et/ou CB2. De préférence, à la fois l'agoniste inverse du récepteur CB1 et/ou CB2 et l'antagoniste neutre du récepteur CB1 et/ou CB2 sont des cannabinoïdes. De préférence, les cannabinoïdes sont la tétrahydrocannabidivarine (THCV) et le cannabidiol (CBD).

Affiliated with

Also associated with

Rating

New pharmaceutical formulation comprising cannabidiol and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with New pharmaceutical formulation comprising cannabidiol and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and New pharmaceutical formulation comprising cannabidiol and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1657225